Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Unaltered influenza disease outcomes in swine prophylactically treated with α-galactosylceramide

Developmental & Comparative Immunology(2020)10.1016/j.dci.2020.103843Source: DataRank Database

Unaltered influenza disease outcomes in swine prophylactically treated with α-galactosylceramide is a research paper published in Developmental & Comparative Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.22)OA: greenTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Darling Mélany de Carvalho Madrid ORCID,Guan Yang ORCID,Bianca L. Artiaga ORCID,Julia C. Loeb ORCID,William L. Castleman ORCID

Live enrichment

PubMed:32871161 PMC:PMC8119227 OpenAlex:https://openalex.org/W3082790085

National Institutes of Health

Grant: HD092286

National Institutes of Health

Grant: HHSN272201300006C

U.S. Department of Agriculture

Grant: 2016–09448

NICHD NIH HHS

Grant: R01 HD092286

FWCI

0.22

Citation Percentile

0.5%

Citation Trend

2021

2022

2024

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8119227

publisherhttps://api.elsevier.com/content/article/PII:S0145305X20303980?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0145305X20303980?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.dci.2020.103843

Fields of Study

Immune Cell Function and InteractionImmune Response and InflammationT-cell and B-cell Immunology

MeSH Terms

Vaccine EfficacyAnimalsGalactosylceramidesHumansInfluenza, HumanInjections, IntramuscularLungLymphocyte ActivationNasal MucosaOrthomyxoviridae InfectionsInfluenza A virusSwineVirus ReplicationMiceNatural Killer T-Cells

Keywords

ImmunologyBiologyNasal administrationVirusInfluenza A virusDiseaseCellVirologyViral replicationMedicineInternal medicineInfluenzaPigsProphylacticΑ-galactosylceramideInvariant Natural Killer T Cells

Sustainable Development Goals

SDG 0: Good health and well-being